Details

NameSymbolSector
GODAVARI DRUGS LTD.GODAVARIPharmaceuticals
Open
129.8
High
134
Low
129.4
Close
133.4
Volume
1065
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

1

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Godavari Drugs is  
Normal
Estimated Stoploss of Godavari Drugs is ₹  
129.4
Godavari Drugs has a  
Bullishℹ
 pattern. 
Formation of  
Normal
 candle pattern indicates the trend direction of Godavari Drugs is  
Unpredictableℹ
. 

Trend

Godavari Drugs is in  
Sideways trendℹ
. 
Price of Godavari Drugs is  
Upℹ
 by  

15.32

%. 
Target
Buy @ 

93.45

Sell @ 

136.53

Current @ 

133.4

Volume

The trade volumes of Godavari Drugs have become  
Deficientℹ
Though the volume trend for Godavari Drugs appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Godavari Drugs is  

Down

 by  

87.53

% 

Valuation

The current market price of Godavari Drugs is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 143cr and total assets worth ₹ 143cr, the balance sheet of Godavari Drugs is:  
Balancedℹ
. 
Cashflow
Godavari Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

28.95% i.e. ₹ 11cr earned in operatingℹ
50% i.e. ₹ 19cr spent in investingℹ
21.05% i.e. ₹ 8cr earned in financingℹ
0% in otherℹ
Godavari Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 18cr earned in operatingℹ
36.11% i.e. ₹ 13cr spent in investingℹ
13.89% i.e. ₹ 5cr spent in financingℹ
0% in otherℹ
Income
The income of Godavari Drugs is  

₹ 27cr

 and  

Profit

 is :  

₹ 1cr

(*Sep 2025)

Godavari Drugs Profit is up by:  

0

% and Income is Up by:  

17.39

% 

(*Sep 2025)

The income of Godavari Drugs is  

₹ 23cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Godavari Drugs Profit is up by:  

100

% and Income is Down by:  

8

% 

(*Jun 2025)

The income of Godavari Drugs is  

₹ 25cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Godavari Drugs Losses increased by:  

0

% and Income is Down by:  

13.79

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.